Selected article for: "cardiovascular disease and chronic kidney disease"
Author: Yiqiong Ma; Bo Diao; Xifeng Lv; Jili Zhu; Wei Liang; Lei Liu; Wenduo Bu; Huiling Cheng; Sihao Zhang; Lianhua Yang; Ming Shi; Guohua Ding; Bo Shen; Huiming Wang
Title: 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China
  • Document date: 2020_2_25
    • ID: b2znv6pa_1
    Snippet: In December 2019, the initially outbreak of COVID-19 in Wuhan city spread rapidly to all over China and even the world, becoming a serious pandemic [1] [2] [3] . As of February 17, 2020, the confirmed COVID-19 case in Wuhan city, nationwide of China, and world globally reached to 37152, 70635, and 71429 respectively [4, 5] . In the patients with COVID-19, some special population should be paid special attention to. Epidemiological survey shows th.....
    Document: In December 2019, the initially outbreak of COVID-19 in Wuhan city spread rapidly to all over China and even the world, becoming a serious pandemic [1] [2] [3] . As of February 17, 2020, the confirmed COVID-19 case in Wuhan city, nationwide of China, and world globally reached to 37152, 70635, and 71429 respectively [4, 5] . In the patients with COVID-19, some special population should be paid special attention to. Epidemiological survey shows that COVID-19 patients with underlined conditions such as diabetes, hypertension, cardiovascular disease or the elderly are not only susceptible, but also often more serious. These patients are at higher risk of admission to intensive care or death [6, 7] . In addition, the profound impact inflicted by COVID-19 on pregnant women and newborns has also been noticed [8, 9] . However, as far as we know, the impact of COVID-19 epidemic on chronic kidney disease patients, especially uremic HD patients has not yet been reported. Considering the large population size of HD patients (There are 7184 registered patients receiving HD treatment in 61 centers in Wuhan city.), the high aggregation and mobility of HD center population, and the low immune function of uremic patients [10] , the situation of HD patients under the COVID-19 epidemic should not be ignored.

    Search related documents:
    Co phrase search for related documents
    • cardiovascular disease and chronic kidney disease patient: 1, 2, 3, 4, 5
    • cardiovascular disease and death care: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and death care intensive admission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and disease patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and elderly cardiovascular disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and elderly cardiovascular disease hypertension: 1, 2, 3, 4, 5, 6, 7, 8
    • cardiovascular disease and elderly cardiovascular disease hypertension diabetes: 1, 2, 3, 4, 5, 6, 7, 8
    • cardiovascular disease and epidemic impact: 1, 2, 3, 4
    • cardiovascular disease and epidemiological survey: 1
    • center population and disease patient: 1, 2
    • center population and epidemic impact: 1
    • center population and HD center population: 1, 2, 3, 4
    • chronic kidney disease patient and disease patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • death care and disease patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • death care and elderly cardiovascular disease: 1
    • death care and epidemic impact: 1, 2, 3, 4, 5
    • death care intensive admission and disease patient: 1, 2
    • death care intensive admission and elderly cardiovascular disease: 1
    • death care intensive admission and epidemic impact: 1, 2